Schätzl H, Schwarzfischer G, Rose D, Gathof B, Weise W, Deinhardt F, Von der Helm K
Max v. Pettenkofer Institute, University of Munich, Germany.
J Med Virol. 1994 Jun;43(2):159-60. doi: 10.1002/jmv.1890430211.
The extent of human T-cell lymphotropic retrovirus HTLV-I and HTLV-II infections in the general population in central Europe has not been investigated fully. Two hundred forty-eight thousand blood donors from southern Germany were examined serologically for antibodies to the human lymphotropic retroviruses HTLV-I and HTLV-II: 0.021% were confirmed positive and 0.056% were "indeterminate". A limited number of seropositives and "indeterminate" samples were analyzed by polymerase chain reaction (PCR): the seropositives were confirmed as positive and 43% of the "indeterminate" samples were PCR-positive. The range of 0.021% HTLV-positives in 248,000 donors, i.e. about two in 10,000 individuals, mirrors closely the published data for the United States.